Weight gain in hormone receptor-positive (HR+) early-stage breast cancer: is it menopausal status or something else?

Purpose This study investigates weight trajectories in pre- versus postmenopausal breast cancer (BC) survivors diagnosed with hormone receptor-positive tumors, with a specific focus on discerning menopausal status and type of endocrine treatment (ET) as risk factors for weight gain during ET.